Avaleht/Aktsiad/NPCE

NPCE

USD

Neuropace Inc. Common Stock

$11.230-0.570 (-4.831%)

Reaalajas hind

Healthcare

Meditsiiniseadmed

Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad

Ettevõtte fundamentaalnäitajad

Kauplemisstatistika

Turunäitajad

Avatud

$11.800

Kõrge

$12.032

Madal

$11.110

Maht

0.33M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

368.3M

Tööstusharu

Meditsiiniseadmed

Riik

United States

Kauplemisstatistika

Keskmine maht

0.29M

Börs

NGM

Valuuta

USD

52 nädala vahemik

Madal $5.45Praegune $11.230Kõrge $18.975

Seotud uudised

4. juuni 2025 · 20:09

GlobeNewswire

NeuroPace Secures Up to $75 Million in Debt Financing

MOUNTAIN VIEW, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (NASDAQ:NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that the Company has

Vaata rohkem

NeuroPace Secures Up to $75 Million in Debt Financing

28. mai 2025 · 10:27

Analyst Upgrades

HC Wainwright & Co. Initiates Coverage On NeuroPace with Buy Rating, Announces Price Target of $18

HC Wainwright & Co. analyst Yi Chen initiates coverage on NeuroPace with a Buy rating and announces Price Target of $18.

Vaata rohkem

HC Wainwright & Co. Initiates Coverage On NeuroPace with Buy Rating, Announces Price Target of $18

27. mai 2025 · 12:00

GlobeNewswire

NeuroPace Announces Preliminary Results from One-Year Data in NAUTILUS Study

-- NeuroPace has completed the primary endpoint analysis of the one-year data from the first and only clinical study to evaluate neuromodulation therapy for idiopathic generalized epilepsy -- Study met the 12-week

Vaata rohkem